Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PoorOpinionon Apr 06, 2018 12:18pm
109 Views
Post# 27843400

RE:RE:RE:RE:RE:RE:RE:RE:RE:Stupid Canadian market

RE:RE:RE:RE:RE:RE:RE:RE:RE:Stupid Canadian market
jfm1330 wrote: It's more than stupid Canadian analysts. As I wrote it's stupid Canadian market. Those who are selling at this ridiculous price these days are not all guided by analysts. Everybody can have a good personal reason to sell a stock at any time, but not the whole market. Many are just selling out of ignorance or lack of patience or because they want to crytalize a profit. They will come to regret it, like those who sold at 1$, 2$, 3$, etc...

It's like the market thinks that the move from 1$ to 10$ was just the company correcting its past mistakes, like a return to respectability, but they still cannot believe Thera will become an elite company that will end up as a model, way above respectability.


lol, usual balance. It secured great terms on a phase III drug that looks like it will pay off hugely. You have to congratulate the management on that success but its going to be hard to replicate that, those deals just arent out there. The likeliest outcome is the next deal is in line with industry average and will be fought for in competition with many other wannabes. Its back to squre one (maybe two) for the next deal, and the next, long road to elite. But dont stop dreaming.

None of that stops plenty of upside in the present deal btw.

Bullboard Posts